U.S. Food and Drug Administration • Center for Drug Evaluation and ResearchSkip navigation
CDER - Center for Drug Evaluation and Research Logo

Drug Information

CDER Home Site Information Comments and Feedback What's New CDER Navigation Bar

First-Time Generics - July 2002

  Generic Drug Name Generic Manufacturer Brand Name Approval Date
1 LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS 10 MG/12.5 MG, 20 MG/12.5 MG, AND 20 MG/25 MG TEVA PHARMACEUTICALS USA PRINIZIDE TABLETS 7/1/02
2 LISINOPRIL TABLETS, USP 2.5 MG, 5 MG, 10 MG, 20 MG, 30 MG, AND 40 MG WATSON LABORATORIES, INC. ZESTRIL TABLETS 7/1/02
3 SEVOFLURANE LIQUID FOR INHALATION 100 % BAXTER HEALTHCARE CORPORATION ULTANE 7/2/02
4 TIZANIDINE HYDROCHLORIDE TABLETS 2 MG (BASE), AND 4 MG (BASE) DR. REDDY'S LABORATORIES, LTD. ZANAFLEX TABLETS 7/3/02
5 NIZATIDINE CAPSULES, USP 150 MG AND 300 MG MYLAN PHARMACEUTICALS, INC. AXID CAPSULES 7/5/02
6 CIPROFLOXACIN TABLETS, USP 100 MG, 250 MG, 500 MG, AND 750 MG DR. REDDY'S LABORATORIES, LTD. CIPRO TABLETS 7/8/02
7 MISOPROSTOL TABLETS 0.1 MG AND 0.2 MG IVAX PHARMACEUTICALS, INC. CYTOTEC TABLETS 7/10/02
8 CARBAMAZEPINE TABLETS, USP (CHEWABLE) 200 MG (NEW STRENGTH) TARO PHARMACEUTICAL INDUSTRIES LTD. TEGRETOL CHEWABLE TABLETS 7/29/02

totop.gif (1525 bytes) Back to Top   Back Back to Approvals

FDA/Center for Drug Evaluation and Research
Last Updated: August 9, 2002
Originator: OGC
HTML by PKS, TA